CA
NZ
UK
AU
IND
US
Super Micro Computer, Inc. (NASDAQ:SMCI) had its target price lowered by JPMorgan Chase & Co. The brokerage revised its estimate from USD 43.00 to USD 40.00 in a research note released Wednesday, as reported by Benzinga. JPMorgan maintained a “neutral” rating on the stock. …
Amazon.com, Inc. (NASDAQ:AMZN)operates a global e-commerce and cloud services platform, providing goods directly and via third-party vendors. It divides its operations into North America, International, and AWS segments.
Market Movers:On Tuesday, the top gainers were Evoke Pharma, Inc. (+132.24%), followed by Davis Commodities Limited. (+63.46%). On the contrary AsiaStrategy (-37.15%), and Sarepta Therapeutics, Inc. (-33.74%) declined the most the same day.
Trivago N.V. (NASDAQ:TRVG)announced its financial results for the third quarter ended September 30, 2025. Total revenue increased 13% year-over-year to EUR 165.6M, led by an 11% rise in Referral Revenue, which reached EUR 161.6M. Thisrepresents the fourth consecutive quarter of overall revenue growth and …
CrowdStrike (NASDAQ:CRWD)has broadened its Agentic Security Workforce by introducing additional mission-ready agents to the Falcon® platform. These new agents follow the initial rollout at Fal.Con 2025 and extend agentic automation to key Falcon platform functions, such as app creation and data onboarding. The expansion …
Fiverr International Ltd.(NYSE:FVRR)reported its third-quarter financial results for 2025, recording total revenue of USD 107.9M, up from USD 99.6M in Q3 2024, representing an 8.3% increase year-over-year. Marketplace revenue declined slightly to USD 73.6M from USD 75.1M in Q3 2024. Annual active buyers totaled …
DXC Technology (NYSE:DXC), a Fortune 500 global IT services provider, has been named a Leader in the 2025 ISG Provider Lens® AWS Ecosystem Partners report. The company received 16 awards globally, securing leading positions across the United States, Asia-Pacific, Germany, and the United Kingdom.
ImmunityBio, Inc. (NASDAQ:IBRX), a biotechnology firm advancing immunotherapies and cell-based treatments for cancer and infectious diseases, announced its financial and operational results for the third quarter and nine months ended September 30, 2025.
Wave Life Sciences Ltd. (NASDAQ:WVE), a clinical-stage biotechnology company developing RNA-based therapeutics, announced plans to present preclinical findings on its investigational obesity candidate WVE-007 (INHBE GalNAc-siRNA) at ObesityWeek® 2025, hosted byThe Obesity Societyin Atlanta.
Gold Resource Corporation (NYSE:GORO) released its financial and operational results for Q3 2025, highlighting production improvements at the Don David Gold Mine in Oaxaca, Mexico.
Please wait processing your request...